NCT00000433View on ClinicalTrials.gov

Blocking Tumor Necrosis Factor in Ankylosing Spondylitis

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 31, 1999

Study Completion Date

March 31, 2002

Conditions
Spondylitis, Ankylosing
Interventions
DRUG

Anti-Tumor Necrosis Factor

Trial Locations (1)

94143-0792

UCSF-Clinical Trials Center, San Francisco

All Listed Sponsors
lead

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

NCT00000433 - Blocking Tumor Necrosis Factor in Ankylosing Spondylitis | Biotech Hunter | Biotech Hunter